Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 2

1(50.0%)

2Total

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02238795Completed

Sepsis-Associated Purpura Fulminans International Registry - Europe

Role: collaborator

NCT02879682Phase 2Completed

nTMS for Motor Mapping of Rolandic Lesions

Role: collaborator

NCT05289583Completed

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

Role: lead

NCT02517723Not ApplicableCompleted

Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder

Role: lead

NCT04814849Completed

Parents' Occupation After Diabetes Onset

Role: collaborator

NCT03018639Completed

Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT

Role: lead

NCT01172977Completed

Neurological Complications at Stroke Patients With Diabetes Mellitus

Role: lead

All 7 trials loaded